Before 2010, higher-income taxpayers were subject to a phase-out rule that curtailed deductions for personal and dependent exemptions. That rule was gone for 2010, 2011 and 2012 but is back for 2013 and beyond.
Irish drugmaker Shire Pharmaceuticals has been ordered to pay a $56.5 million fine to settle claims that it exaggerated the benefits of several of its drugs, including Adderall XR and Vyvanse, both used to treat attention deficit hyperactivity disorder (ADHD).
Boehringer Ingelheim. Germany's Boehringer Ingleheim manufactures drugs that treat a wide variety of conditions. Side effects from the company's blood thinner Pradaxa led to thousands of lawsuits and millions of dollars in settlements, and its Type 2 diabetes drug Tradjenta could follow a similar path. One of the top-selling pharmaceutical companies in the world, Boehringer Ingelheimâs revenue totaled $15.1 billion in 2014.